Home › NDC Lookup › Drug shortages › Ropivacaine Hydrochloride Injection

This page is curated, coded, and maintained by

Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy

Ropivacaine Hydrochloride Injection shortage

Ropivacaine Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 49 affected products. The reported reason: Other; Delay in shipping of the drug; Demand increase for the drug. This page was last refreshed from FDA data on Oct 1, 2026.

Current ⚠ Supply risk: Low Anesthesia 49 products 5 manufacturers 3,115 days · 8.5 yr First posted Mar 23, 2018 Updated Sep 17, 2026
Here’s the bottom line

Ropivacaine hydrochloride injection has been on the FDA shortage list for over a year, with some suppliers on backorder due to shipping delays and rising demand. Other makers not reporting a shortage still list this medicine as available.

Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
49
Affected NDCs
5
Reporting manufacturers
5/5
Reporting mfrs supplying
4/4
Affected strengths supplied
24%
NDCs unavailable
3,115
Days in shortage
28,915
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 1, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Ropivacaine Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
49 NDCs
Available 34 Limited 3 Unavailable 12
Affected strengths still supplied
Among manufacturers reporting this shortage
4/4 strengths
Sourceable 4
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
5/5 makers
With supply 5
✓ Other manufacturers not reporting a shortage
Still-marketed Ropivacaine Hydrochloride Injection from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Hikma Pharmaceuticals USA Inc. Baxter Healthcare Corporation Fresenius Kabi USA, LLC Caplin Steriles Limited
See all other options & details →
Shortage timeline
  1. Sep 17, 2026
    Currently in shortage
    49 of 49 products affected.
  2. Sep 15, 2026
    FDA refreshed this shortage record
    22 products updated.
  3. Sep 11, 2026
    FDA refreshed this shortage record
    10 products updated.
  4. Aug 18, 2026
    FDA refreshed this shortage record
    6 products updated.
  5. Jun 10, 2026
    FDA refreshed this shortage record
    4 products updated.
  6. Dec 22, 2020
    More presentations reported
    4 more products added to the shortage.
  7. Mar 27, 2018
    More presentations reported
    6 more products added to the shortage.
  8. Mar 23, 2018
    First reported to the FDA
    39 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Caplin Steriles, Ltd. 📞 888-229-0001 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) NDC 43066-0019-10 — Available Check wholesalers for inventory; Marketed by Baxter —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) NDC 43066-0015-10 — Limited Availability Check wholesalers for inventory; Marketed by Baxter Other
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) NDC 43066-0023-10 — Limited Availability Limited supply; Check wholesalers for inventory; Marketed by Baxter Other
Current Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) NDC 43066-0027-10 — Available Check wholesalers for inventory; Marketed by Baxter —
Manufacturer: Eugia US LLC 📞 888-238-7880 7 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) NDC 55150-0196-99 — Available Check wholesalers for inventory —
Current Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) NDC 55150-0201-20 — Available Check wholesalers for inventory —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) NDC 55150-0195-20 — Unavailable On backorder. Recovery: TBD. Check wholesalers for inventory Demand increase for the drug
Current Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) NDC 55150-0200-10 — Available Check wholesalers for inventory —
Current Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) NDC 55150-0199-20 — Unavailable On backorder. Recovery: TBD. Check wholesalers for inventory Demand increase for the drug
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) NDC 55150-0197-20 — Available Check wholesalers for inventory —
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) NDC 55150-0198-30 — Available Check wholesalers for inventory —
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 22 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) NDC 63323-0285-65 — Available Check wholesalers for inventory —
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) NDC 63323-0285-63 — Unavailable Estimated recovery: TBD Other
Current Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) NDC 63323-0286-35 — Available Check wholesalers for inventory —
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) NDC 63323-0285-10 — Unavailable Estimated recovery: TBD Demand increase for the drug
Current Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) NDC 63323-0287-21 — Available Check wholesalers for inventory —
Current Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) NDC 65219-0632-20 — Available — —
Current Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) NDC 63323-0286-00 — Available — —
Current Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) NDC 63323-0288-20 — Unavailable Estimated recovery: TBD Delay in shipping of the drug
Current Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) NDC 63323-0288-21 — Available — —
Current Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) NDC 63323-0288-11 — Available — —
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) NDC 63323-0285-23 — Available Check wholesalers for inventory —
Current Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) NDC 65219-0632-10 — Available — —
Current Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) NDC 63323-0286-31 — Unavailable Estimated recovery: TBD Delay in shipping of the drug
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) NDC 63323-0285-13 — Available Check wholesaler for inventory —
Current Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) NDC 63323-0286-63 — Available — —
Current Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) NDC 63323-0287-20 — Unavailable Estimated recovery: TBD Demand increase for the drug
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) NDC 63323-0285-20 — Unavailable Estimated recovery: TBD Other
Current Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) NDC 63323-0286-23 — Available — —
Current Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) NDC 63323-0286-20 — Unavailable Estimated recovery: TBD Delay in shipping of the drug
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) NDC 63323-0285-61 — Unavailable Estimated recovery: TBD Other
Current Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) NDC 63323-0285-64 — Available — —
Current Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) NDC 63323-0288-10 — Unavailable Estimated recovery: TBD Delay in shipping of the drug
Manufacturer: InfoRLife SA 📞 Sagent: 866-625-1618 6 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) NDC 25021-0671-66 — Limited Availability Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals Other
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) NDC 25021-0671-82 — Available Marketed by Sagent Pharmaceuticals —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) NDC 25021-0671-87 — Available Marketed by Sagent Pharmaceuticals —
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) NDC 25021-0652-82 — Available Marketed by Sagent Pharmaceuticals —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) NDC 25021-0671-67 — Unavailable Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals Other
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) NDC 25021-0652-87 — Available Marketed by Sagent Pharmaceuticals —
Manufacturer: Somerset Therapeutics, LLC 📞 732-554-1019 10 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) NDC 70069-0061-10 — Available — —
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) NDC 70069-0064-10 — Available — —
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) NDC 70069-0064-25 — Available — —
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) NDC 70069-0064-01 — Available — —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) NDC 70069-0062-10 — Available — —
Current Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) NDC 70069-0063-25 — Available — —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) NDC 70069-0062-25 — Available — —
Current Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) NDC 70069-0067-10 — Available — —
Current Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) NDC 70069-0067-25 — Available — —
Current Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) NDC 70069-0061-25 — Available — —

These rows are manufacturer reports to the FDA for Ropivacaine Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Ropivacaine Hydrochloride Injection? options further down this page.

Why is Ropivacaine Hydrochloride Injection in shortage?

A note from Dr. Brian Staiger, PharmD

There are a few different things going on with ropivacaine right now, depending on the manufacturer. More people need this medication than usual (a demand increase), and some manufacturers are also dealing with shipping hold-ups getting product out the door — both of which have tightened supplies across several strengths and package sizes.

Here's a quick breakdown of what's currently unavailable or limited by manufacturer:

  • Eugia US LLC: The 2 mg/mL and 7.5 mg/mL strengths are on backorder due to higher-than-usual demand; no recovery date has been set yet. Their 5 mg/mL and 10 mg/mL strengths are still available.
  • InfoRLife SA (marketed by Sagent Pharmaceuticals): One package size of the 2 mg/mL is completely unavailable, and another package size of the 2 mg/mL has limited supply; no recovery date is set for either. Other package sizes of the 2 mg/mL and 5 mg/mL remain available.
  • Fresenius Kabi USA (Naropin brand): The 5 mg/mL and 10 mg/mL are out due to shipping delays, the 7.5 mg/mL is out due to demand, and some 2 mg/mL package sizes are also unavailable — all with no set recovery date. Certain package sizes of the 2 mg/mL and 5 mg/mL are still available.
  • Caplin Steriles (marketed by Baxter): The 2 mg/mL and one package size of the 5 mg/mL are listed as limited supply; no specific reason beyond "other" was shared publicly.
FDA reason code(s): Other; Delay in shipping of the drug; Demand increase for the drug

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Ropivacaine Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Ropivacaine Hydrochloride Injection?

A note from Dr. Brian Staiger, PharmD

Ropivacaine hydrochloride injection — a local anesthetic used during procedures and for pain control — is currently on the FDA's shortage list. This has been an ongoing situation for over a year, but the overall supply risk remains low.

Here is the part that matters most for you: every strength still has an available source. The 2 mg/mL, 5 mg/mL, 7.5 mg/mL, and 10 mg/mL strengths are all reported as available from at least one manufacturer. Some individual products within certain strengths are on backorder or limited, but no strength is completely out of supply.

The FDA lists the reasons as increased demand, shipping delays, and "other." All five manufacturers on this record are still reporting supply, which is reassuring. Estimated recovery dates for the affected items are listed as "to be determined."

What you can do:

  1. Do not stop, skip, or change your dose on your own.
  2. Ask your pharmacy to order your strength — they can check wholesalers and other manufacturers, since this medicine is given by a healthcare provider.
  3. If one product is hard to find, the same medicine is made by other companies (such as Hikma, Baxter, Fresenius Kabi, Caplin, Somerset, and Sagent); your pharmacy may be able to source one, though it may not be in local stock.
  4. If your exact product can't be found, ask your prescriber or pharmacist about options.

Manufacturer contact numbers are listed on this page for reference. This information comes from national, manufacturer-reported data and may not match your local pharmacy's actual stock.

See “Where else can I get Ropivacaine Hydrochloride Injection?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Ropivacaine guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Ropivacaine guide →

Where else can I get Ropivacaine Hydrochloride Injection?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Ropivacaine Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 2 mg/mL Injection, Solution · Epidural, Infiltration, Perineural Hikma Pharmaceuticals USA Inc. 00143-9195-24
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 5 mg/mL Injection, Solution · Epidural, Infiltration, Perineural Hikma Pharmaceuticals USA Inc. 00143-9197-24
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 2 mg/mL Injection · Epidural, Infiltration Hikma Pharmaceuticals USA Inc. 00143-9263-10
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 5 mg/mL Injection · Epidural, Infiltration Hikma Pharmaceuticals USA Inc. 00143-9264-10
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 7.5 mg/mL Injection · Epidural Hikma Pharmaceuticals USA Inc. 00143-9265-10
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 10 mg/mL Injection · Epidural Hikma Pharmaceuticals USA Inc. 00143-9266-10
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 2 mg/mL Injection, Solution · Epidural, Infiltration Baxter Healthcare Corporation 43066-0152-10
Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL Injection, Solution · Epidural, Infiltration Fresenius Kabi USA, LLC 63323-0285-28
Naropin ROPIVACAINE HYDROCHLORIDE 5 mg/mL Injection, Solution · Epidural, Infiltration, Perineural Fresenius Kabi USA, LLC 63323-0286-27
Naropin ROPIVACAINE HYDROCHLORIDE 10 mg/mL Injection, Solution · Epidural Fresenius Kabi USA, LLC 63323-0288-27
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 2 mg/mL Injection · Epidural, Infiltration, Perineural Caplin Steriles Limited 65145-0107-10
Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE 5 mg/mL Injection · Epidural, Infiltration, Perineural Caplin Steriles Limited 65145-0108-10
Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Ropivacaine Hydrochloride 5 mg/mLNDC 43066-0019-10 Baxter 10 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 55150-0197-20 Eugia 25 vials — AP FDA listed
Naropin 5 mg/mLNDC 63323-0286-27 Fresenius 25 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 65145-0108-10 Caplin 10 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 68462-0778-55 Glenmark 25 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 70069-0063-25 Somerset 25 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 71288-0734-21 Meitheal 25 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 72603-0217-25 NorthStar 25 vials — AP Discontinued
Ropivacaine Hydrochloride 5 mg/mLNDC 65145-0109-10 Caplin 10 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 85766-0098-01 Sportpharm 1 vial — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 55150-0198-30 Eugia 25 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 70069-0064-01 Somerset 1 vial — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 83854-0014-05 Anthea 5 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 68462-0794-62 Glenmark 25 vials — AP FDA listed
Naropin 5 mg/mLNDC 00404-9924-30 Henry 1 vial — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 72603-0218-25 NorthStar 25 vials — AP Discontinued
Ropivacaine Hydrochloride 5 mg/mLNDC 84549-0164-25 ProPharma 30 ml — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 70121-1734-07 Amneal 10 pouches — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 70121-1735-07 Amneal 10 pouches — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 00143-9197-24 Hikma 100 ml — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 43066-0023-10 Baxter 10 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 71288-0735-31 Meitheal 25 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 72572-0707-10 Civica, 10 vials — AP FDA listed
Ropivacaine Hydrochloride 5 mg/mLNDC 85766-0097-30 Sportpharm 1 vial — AP FDA listed
Ropivacaine Hydrochloride 2 mg/mLNDC 00143-9263-10 Hikma 10 vials — AP FDA listed
Ropivacaine Hydrochloride 2 mg/mLNDC 43066-0015-10 Baxter 10 vials — AP FDA listed
Ropivacaine Hydrochloride 2 mg/mLNDC 55150-0195-20 Eugia 25 vials — AP FDA listed
Naropin 2 mg/mLNDC 63323-0285-28 Fresenius 25 vials — AP FDA listed
Ropivacaine Hydrochloride 2 mg/mLNDC 65145-0107-10 Caplin 10 vials — AP FDA listed
Ropivacaine Hydrochloride 2 mg/mLNDC 68462-0793-55 Glenmark 25 vials — AP FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Ropivacaine Hydrochloride Injection — that fall in the same broad treatment class (local anesthetics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Lidocaine Hcl Bupivacaine Hcl Mepivacaine Hcl Lidocaine Hcl/Epinephrine Bupivacaine Hcl/Epinephrine Chloroprocaine Hcl Benzocaine/Benzalk Chl

Identity & classification

GCN Seq No 028220
GCN 46084
HICL code 036674
Ingredient (HICL) Ropivacaine Hcl/Pf
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H0
Therapeutic class — intermediate (HIC2) Act On Non-Autonomic Nervous System
HIC3 code H0A
Therapeutic class — specific (HIC3) Local Anesthetics
AHFS code 72:00.00.00
AHFS class Local Anesthetics
FDB label name ROPIVACAINE 0.5% 100 MG/20 ML
FDB brand name Ropivacaine Hcl
Legend status F — Federal legend — prescription drug or device
GPI-1469100070102020
GPI classRopivacaine HCl
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other anesthesia shortages

Glycopyrrolate Injection To Be Discontinued · 4 NDCS Succinylcholine Chloride Injection To Be Discontinued · 1 NDC Desflurane Liquid For Inhalation To Be Discontinued · 1 NDC Ketamine Hydrochloride Injection To Be Discontinued · 1 NDC Rocuronium Bromide Injection Current · 26 NDCS Etomidate Injection Current · 18 NDCS Dexmedetomidine Hydrochloride Injection Current · 59 NDCS Bupivacaine Hydrochloride Injection Current · 62 NDCS

Ropivacaine Hydrochloride Injection shortage FAQs

Is Ropivacaine Hydrochloride Injection in shortage?
Yes — the FDA currently lists Ropivacaine Hydrochloride Injection in shortage (status: “Current”, first reported Mar 23, 2018). 49 of 49 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Ropivacaine Hydrochloride Injection in shortage?
The manufacturer-reported reason on file with the FDA: Other; Delay in shipping of the drug; Demand increase for the drug.
Which products are affected?
Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) (NDC 43066-0019-10); Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) (NDC 43066-0015-10); Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) (NDC 43066-0023-10). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Ropivacaine Hydrochloride Injection be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Ropivacaine Hydrochloride somewhere?
Other manufacturers (Hikma Pharmaceuticals USA Inc., Baxter Healthcare Corporation, Fresenius Kabi USA, LLC and others) still market it and have not reported a shortage. See “Where else can I get Ropivacaine Hydrochloride Injection?” above — stock still varies by pharmacy.
What should I do if I take Ropivacaine Hydrochloride Injection?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Ropivacaine Hydrochloride Injection shortage?

Ask a pharmacist about this shortage →

View Ropivacaine Hydrochloride Injection on the FDA drug-shortage database →

How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages